STALEY CAPITAL ADVISERS’s Phathom Pharmaceuticals PHAT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $95.9K | Hold |
10,000
| – | – | ﹤0.01% | 188 |
|
|
2025
Q1 | $62.7K | Hold |
10,000
| – | – | ﹤0.01% | 187 |
|
|
2024
Q4 | $81.2K | Hold |
10,000
| – | – | ﹤0.01% | 176 |
|
|
2024
Q3 | $181K | Hold |
10,000
| – | – | 0.01% | 176 |
|
|
2024
Q2 | $103K | Hold |
10,000
| – | – | ﹤0.01% | 176 |
|
|
2024
Q1 | $106K | Hold |
10,000
| – | – | 0.01% | 180 |
|
|
2023
Q4 | $91.3K | Hold |
10,000
| – | – | ﹤0.01% | 174 |
|
|
2023
Q3 | $104K | Hold |
10,000
| – | – | 0.01% | 168 |
|
|
2023
Q2 | $143K | Hold |
10,000
| – | – | 0.01% | 175 |
|
|
2023
Q1 | $71K | Hold |
10,000
| – | – | ﹤0.01% | 175 |
|
|
2022
Q4 | $112K | Hold |
10,000
| – | – | 0.01% | 163 |
|
|
2022
Q3 | $111K | Buy |
+10,000
| New | +$111K | 0.01% | 164 |
|